Header Logo

Connection

AARON THRIFT to Risk Factors

Back to Details
This is a "connection" page, showing publications AARON THRIFT has written about Risk Factors.
AARON THRIFT
Connection Strength
2.963
Risk Factors
  1. Validation of a pre-endoscopy risk score for predicting the presence of gastric intestinal metaplasia in a U.S. population. Gastrointest Endosc. 2023 10; 98(4):569-576.e1.
    View in: PubMed
    Score: 0.068
  2. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol. 2023 05; 20(5):338-349.
    View in: PubMed
    Score: 0.068
  3. Risk stratification for hepatocellular cancer among patients with cirrhosis using a hepatic fat polygenic risk score. PLoS One. 2023; 18(2):e0282309.
    View in: PubMed
    Score: 0.067
  4. Preventable causes of cancer in Texas by race/ethnicity: Major modifiable risk factors in the population. PLoS One. 2022; 17(10):e0274905.
    View in: PubMed
    Score: 0.066
  5. Hepatocellular and extrahepatic cancers in non-alcoholic fatty liver disease: A systematic review and meta-analysis. Eur J Cancer. 2022 09; 173:250-262.
    View in: PubMed
    Score: 0.065
  6. Recent Decline in the Incidence of Hepatocellular Carcinoma in the United States. Clin Gastroenterol Hepatol. 2023 08; 21(9):2418-2420.e3.
    View in: PubMed
    Score: 0.065
  7. Polygenic Risk Scores for Follow Up After Colonoscopy and Polypectomy: Another Tool for Risk Stratification and Planning Surveillance? Clin Gastroenterol Hepatol. 2023 01; 21(1):29-32.
    View in: PubMed
    Score: 0.065
  8. The Prevalence and Determinants of NAFLD and MAFLD and Their Severity in the VA Primary Care Setting. Clin Gastroenterol Hepatol. 2023 05; 21(5):1252-1260.e5.
    View in: PubMed
    Score: 0.065
  9. Missed Opportunities for Screening or Surveillance Among Patients with Newly Diagnosed Non-cardia Gastric Adenocarcinoma. Dig Dis Sci. 2023 03; 68(3):761-769.
    View in: PubMed
    Score: 0.064
  10. Race/Ethnicity and Birthplace as Risk Factors for Gastric Intestinal Metaplasia in a Multiethnic United States Population. Am J Gastroenterol. 2022 02 01; 117(2):280-287.
    View in: PubMed
    Score: 0.063
  11. Associations of Duration, Intensity, and Quantity of Smoking With Risk of Gastric Intestinal Metaplasia. J Clin Gastroenterol. 2022 01 01; 56(1):e71-e76.
    View in: PubMed
    Score: 0.062
  12. Risk Score Using Demographic and Clinical Risk Factors Predicts Gastric Intestinal Metaplasia Risk in a U.S. Population. Dig Dis Sci. 2022 09; 67(9):4500-4508.
    View in: PubMed
    Score: 0.062
  13. Preventable causes of cancer in Texas by race/ethnicity: tobacco smoking. Epidemiol Health. 2021; 43:e2021046.
    View in: PubMed
    Score: 0.060
  14. Gastric Cancer Epidemiology. Gastrointest Endosc Clin N Am. 2021 Jul; 31(3):425-439.
    View in: PubMed
    Score: 0.060
  15. Global burden and epidemiology of Barrett oesophagus and oesophageal cancer. Nat Rev Gastroenterol Hepatol. 2021 06; 18(6):432-443.
    View in: PubMed
    Score: 0.059
  16. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance. Gastrointest Endosc Clin N Am. 2021 Jan; 31(1):1-26.
    View in: PubMed
    Score: 0.057
  17. Response to Zhu and Xu. Am J Gastroenterol. 2020 10; 115(10):1725.
    View in: PubMed
    Score: 0.057
  18. Does Risk of Progression from Barrett's Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies? Dig Dis Sci. 2021 06; 66(6):1965-1973.
    View in: PubMed
    Score: 0.056
  19. Increasing Incidence of Advanced Non-cardia Gastric Cancers Among Younger Hispanics in the USA. Dig Dis Sci. 2021 05; 66(5):1669-1672.
    View in: PubMed
    Score: 0.056
  20. Dietary Factors and Gastric Intestinal Metaplasia Risk Among US Veterans. Dig Dis Sci. 2021 05; 66(5):1600-1610.
    View in: PubMed
    Score: 0.056
  21. Burden of Pancreatic Cancer: From Epidemiology to Practice. Clin Gastroenterol Hepatol. 2021 05; 19(5):876-884.
    View in: PubMed
    Score: 0.055
  22. Demographic and Lifestyle Risk Factors for Gastric Intestinal Metaplasia Among US Veterans. Am J Gastroenterol. 2020 03; 115(3):381-387.
    View in: PubMed
    Score: 0.055
  23. Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients. Dig Dis Sci. 2020 09; 65(9):2691-2699.
    View in: PubMed
    Score: 0.054
  24. Sex and Race Disparities in the Incidence of Hepatocellular Carcinoma in the United States Examined through Age-Period-Cohort Analysis. Cancer Epidemiol Biomarkers Prev. 2020 01; 29(1):88-94.
    View in: PubMed
    Score: 0.054
  25. Preventable causes of cancer in Texas by race/ethnicity: Alcohol consumption. Alcohol. 2020 06; 85:21-26.
    View in: PubMed
    Score: 0.053
  26. Burden of Gastric Cancer. Clin Gastroenterol Hepatol. 2020 03; 18(3):534-542.
    View in: PubMed
    Score: 0.053
  27. Risk and Predictors of Esophageal and Stomach Cancers in HIV-Infected Veterans: A Matched Cohort Study. J Acquir Immune Defic Syndr. 2019 07 01; 81(3):e65-e72.
    View in: PubMed
    Score: 0.052
  28. Factors associated with favorable survival outcomes for Asians with hepatocellular carcinoma: A sequential matching cohort study. PLoS One. 2019; 14(4):e0214721.
    View in: PubMed
    Score: 0.051
  29. Barrett's Esophagus and Esophageal Adenocarcinoma: How Common Are They Really? Dig Dis Sci. 2018 Aug; 63(8):1988-1996.
    View in: PubMed
    Score: 0.049
  30. Factors Associated With Recurrence of Barrett's Esophagus After Radiofrequency Ablation. Clin Gastroenterol Hepatol. 2019 01; 17(1):65-72.e5.
    View in: PubMed
    Score: 0.049
  31. Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Am J Gastroenterol. 2018 08; 113(8):1148-1155.
    View in: PubMed
    Score: 0.049
  32. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic?Variants. Gastroenterology. 2018 04; 154(5):1273-1281.e3.
    View in: PubMed
    Score: 0.047
  33. Alcohol, smoking and risk of oesophago-gastric cancer. Best Pract Res Clin Gastroenterol. 2017 Oct; 31(5):509-517.
    View in: PubMed
    Score: 0.046
  34. External Validation of the Michigan Barrett's Esophagus Prediction Tool. Clin Gastroenterol Hepatol. 2017 07; 15(7):1124-1126.
    View in: PubMed
    Score: 0.045
  35. Risk Profiles for Barrett's Esophagus Differ between New and Prevalent, and Long- and Short-Segment Cases. PLoS One. 2016; 11(12):e0169250.
    View in: PubMed
    Score: 0.044
  36. Shiftwork Is Not Associated with Increased Risk of NAFLD: Findings from the National Health and Nutrition Examination Survey. Dig Dis Sci. 2017 02; 62(2):526-533.
    View in: PubMed
    Score: 0.044
  37. Acculturation and Nonalcoholic Fatty Liver Disease Risk Among Hispanics of Mexican Origin: Findings From the National Health and Nutrition Examination Survey. Clin Gastroenterol Hepatol. 2017 02; 15(2):310-312.
    View in: PubMed
    Score: 0.043
  38. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma. Curr Opin Gastroenterol. 2016 07; 32(4):319-24.
    View in: PubMed
    Score: 0.043
  39. Weight Change and Weight Cycling Are?Not?Associated With Risk of Barrett's?Esophagus. Clin Gastroenterol Hepatol. 2016 12; 14(12):1839-1840.
    View in: PubMed
    Score: 0.042
  40. The epidemic of oesophageal carcinoma: Where are we now? Cancer Epidemiol. 2016 Apr; 41:88-95.
    View in: PubMed
    Score: 0.041
  41. Premature Birth and Large for Gestational Age Are Associated with Risk of Barrett's Esophagus in Adults. Dig Dis Sci. 2016 Apr; 61(4):1139-47.
    View in: PubMed
    Score: 0.041
  42. Mendelian randomization study of height and risk of colorectal cancer. Int J Epidemiol. 2015 Apr; 44(2):662-72.
    View in: PubMed
    Score: 0.039
  43. Mendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2015 Jul; 24(7):1024-31.
    View in: PubMed
    Score: 0.039
  44. Risk factors and populations at risk: selection of patients for screening for Barrett's oesophagus. Best Pract Res Clin Gastroenterol. 2015 Feb; 29(1):41-50.
    View in: PubMed
    Score: 0.038
  45. Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study. J Natl Cancer Inst. 2014 Nov; 106(11).
    View in: PubMed
    Score: 0.038
  46. Alcohol and the risk of Barrett's esophagus: a pooled analysis from the International BEACON Consortium. Am J Gastroenterol. 2014 Oct; 109(10):1586-94.
    View in: PubMed
    Score: 0.037
  47. Fat mass by bioelectrical impedance analysis is not associated with increased risk of Barrett esophagus. J Clin Gastroenterol. 2014 Mar; 48(3):218-23.
    View in: PubMed
    Score: 0.036
  48. Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by Mendelian randomization. Clin Gastroenterol Hepatol. 2014 Oct; 12(10):1667-76.e1.
    View in: PubMed
    Score: 0.036
  49. Can we really predict risk of cancer? Cancer Epidemiol. 2013 Aug; 37(4):349-52.
    View in: PubMed
    Score: 0.034
  50. The influence of prediagnostic demographic and lifestyle factors on esophageal squamous cell carcinoma survival. Int J Cancer. 2012 Sep 01; 131(5):E759-68.
    View in: PubMed
    Score: 0.031
  51. Maternal smoking during pregnancy among Aboriginal women in New South Wales is linked to social gradient. Aust N Z J Public Health. 2011 Aug; 35(4):337-42.
    View in: PubMed
    Score: 0.030
  52. Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease. Lancet Gastroenterol Hepatol. 2024 Feb; 9(2):159-169.
    View in: PubMed
    Score: 0.018
  53. Risk Stratification Model for Hepatocellular Cancer in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2023 12; 21(13):3296-3304.e3.
    View in: PubMed
    Score: 0.017
  54. Risk factors for HCC in contemporary cohorts of patients with cirrhosis. Hepatology. 2023 03 01; 77(3):997-1005.
    View in: PubMed
    Score: 0.017
  55. Development and Validation of the Houston-BEST, a Barrett's Esophagus Risk Prediction Model Adaptable to Electronic Health Records. Clin Gastroenterol Hepatol. 2023 08; 21(9):2424-2426.e0.
    View in: PubMed
    Score: 0.016
  56. External validation of a model determining risk of neoplastic progression of Barrett's esophagus in a cohort of U.S. veterans. Gastrointest Endosc. 2022 06; 95(6):1113-1122.
    View in: PubMed
    Score: 0.016
  57. A comprehensive re-assessment of the association between vitamin D and cancer susceptibility using Mendelian randomization. Nat Commun. 2021 01 11; 12(1):246.
    View in: PubMed
    Score: 0.015
  58. Sex Differences in the Risk of Barrett's Esophagus Associated With the Metabolic Effects of Obesity. J Clin Gastroenterol. 2020 10; 54(9):795-800.
    View in: PubMed
    Score: 0.014
  59. Risk of Cirrhosis and Hepatocellular Cancer in Patients With NAFLD and Normal Liver Enzymes. Hepatology. 2020 10; 72(4):1242-1252.
    View in: PubMed
    Score: 0.014
  60. Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterology. 2020 12; 159(6):2065-2076.e1.
    View in: PubMed
    Score: 0.014
  61. Prevalence of Barrett's esophagus and performance of societal?screening guidelines in an unreferred primary care population of U.S. veterans. Gastrointest Endosc. 2021 02; 93(2):409-419.e1.
    View in: PubMed
    Score: 0.014
  62. Prevalence of Gastric Intestinal Metaplasia in a Multiethnic US Veterans Population. Clin Gastroenterol Hepatol. 2021 02; 19(2):269-276.e3.
    View in: PubMed
    Score: 0.014
  63. Risk Prediction Models for Barrett's Esophagus Discriminate Well and Are Generalizable in an External Validation Study. Dig Dis Sci. 2020 10; 65(10):2992-2999.
    View in: PubMed
    Score: 0.014
  64. Shared Genetic Etiology of Obesity-Related Traits and Barrett's Esophagus/Adenocarcinoma: Insights from Genome-Wide Association Studies. Cancer Epidemiol Biomarkers Prev. 2020 02; 29(2):427-433.
    View in: PubMed
    Score: 0.013
  65. Association Between Levels of Sex Hormones and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus. Clin Gastroenterol Hepatol. 2020 11; 18(12):2701-2709.e3.
    View in: PubMed
    Score: 0.013
  66. No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study. Clin Gastroenterol Hepatol. 2019 10; 17(11):2227-2235.e1.
    View in: PubMed
    Score: 0.013
  67. Changing Trends in Colorectal Cancers (Detected by Screening, During Screening Intervals, or Associated With Nonadherence) Identify Possible Health Care System Quality Measures. Gastroenterology. 2019 02; 156(3):809-811.
    View in: PubMed
    Score: 0.012
  68. Information on Genetic Variants Does Not Increase Identification of Individuals at Risk of Esophageal Adenocarcinoma Compared to Clinical Risk Factors. Gastroenterology. 2019 01; 156(1):43-45.
    View in: PubMed
    Score: 0.012
  69. Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease. Gastroenterology. 2018 12; 155(6):1828-1837.e2.
    View in: PubMed
    Score: 0.012
  70. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. Br J Cancer. 2018 04; 118(8):1123-1129.
    View in: PubMed
    Score: 0.012
  71. The Annual Risk of Esophageal Adenocarcinoma Does Not Decrease Over Time in Patients With Barrett's Esophagus. Am J Gastroenterol. 2017 Jul; 112(7):1049-1055.
    View in: PubMed
    Score: 0.011
  72. Clinical Manifestations of Helicobacter pylori-Negative Gastritis. Clin Gastroenterol Hepatol. 2017 Jul; 15(7):1037-1046.e3.
    View in: PubMed
    Score: 0.011
  73. Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection. J Hepatol. 2017 02; 66(2):355-362.
    View in: PubMed
    Score: 0.011
  74. Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma. Gut. 2017 10; 66(10):1739-1747.
    View in: PubMed
    Score: 0.011
  75. Common variants in the obesity-associated genes FTO and MC4R are not associated with risk of colorectal cancer. Cancer Epidemiol. 2016 10; 44:1-4.
    View in: PubMed
    Score: 0.011
  76. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. Int J Epidemiol. 2016 06; 45(3):884-95.
    View in: PubMed
    Score: 0.011
  77. Risk factors for Barrett's esophagus compared between African Americans and non-Hispanic Whites. Am J Gastroenterol. 2014 Dec; 109(12):1870-80.
    View in: PubMed
    Score: 0.010
  78. Screen time and metabolic risk factors among adolescents. Arch Pediatr Adolesc Med. 2010 Jul; 164(7):643-9.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.